GE Healthcare Technologies Inc header image

GE Healthcare Technologies Inc

GEHC

Equity

ISIN null / Valor 123735674

NASDAQ (2025-11-20)
USD 74.75+3.37%

GE Healthcare Technologies Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GE Healthcare Technologies Inc is a leading provider of medical imaging products and solutions, with a focus on delivering precise and efficient care across various disease states. Through the acquisition of MIM Software, the company has expanded its capabilities in AI-enabled imaging analysis and workflow tools, enhancing its offerings to healthcare professionals. GE Healthcare Technologies Inc is committed to leveraging technology to improve patient outcomes and streamline clinical workflows in the healthcare industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (24.10.2025):

GE Healthcare Technologies Inc reported its second quarter 2025 financial results, achieving a 3% year-over-year revenue growth to $5.0 billion and an increase in net income to $486 million. The company also raised its full-year 2025 guidance, reflecting strong operational performance and improved cash flow from operating activities.

Revenue Growth

Revenues grew by 3% year-over-year to $5.0 billion, driven by robust performance in the U.S., Europe, Middle East, and Africa. Organic revenue growth was 2%, with total company book-to-bill ratio at 1.07 times and orders increasing by 3% organically.

Profitability

Net income margin improved to 9.7% from 8.9% in the prior year, benefiting from lower tax and interest expenses. However, the adjusted EBIT margin slightly decreased to 14.6% from 15.3%, impacted by tariffs but partially offset by productivity and volume gains.

Earnings Per Share

Diluted earnings per share (EPS) rose to $1.06 compared to $0.93 the previous year. Adjusted EPS also increased to $1.06 from $1.00, supported by lower tax and interest expenses.

Cash Flow

Cash flow from operating activities surged to $94 million, a significant improvement from a negative $119 million year-over-year. Free cash flow also turned positive at $7 million, up from negative $182 million.

Full-Year 2025 Guidance

GE Healthcare Technologies Inc raised its full-year 2025 guidance, now expecting approximately 3% organic revenue growth, adjusted EBIT margins between 15.2% and 15.4%, adjusted EPS ranging from $4.43 to $4.63, and free cash flow of at least $1.4 billion.

Summarized from source with an LLMView Source

Key figures

-12.0%1Y
%3Y
%5Y

Performance

36.6%1Y
32.6%3Y
32.6%5Y

Volatility

Market cap

34050 M

Market cap (USD)

Daily traded volume (Shares)

8,322,431

Daily traded volume (Shares)

1 day high/low

79.16 / 77.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%EUR 35.45
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%CHF 95.34
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%CHF 133.00
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%CHF 70.10
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.97%CHF 67.40
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%CHF 8.34
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%EUR 20.50
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%DKK 577.00
Ardent Health Partners Inc
Ardent Health Partners Inc Ardent Health Partners Inc Valor: 136301364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 8.64
Alk-Abello A/S
Alk-Abello A/S Alk-Abello A/S Valor: 117689788
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%DKK 232.20